trending Market Intelligence /marketintelligence/en/news-insights/trending/eoWmSYFS0bQq1m1Xu1BmSQ2 content esgSubNav
In This List

Australian Pharmaceutical sells entire shareholding in Sigma

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Australian Pharmaceutical sells entire shareholding in Sigma

Australian Pharmaceutical Industries Ltd. sold 137,264,592 shares of Sigma Healthcare Ltd. — its entire shareholding in the company.

The share sale follows a rejected takeover offer by API to acquire Rowville, Australia-based Sigma in March. The offer consisted of 0.31 of an API share and 23 Australian cents in cash per Sigma share.

Sigma, which is focused on wholesale and distribution of pharmaceutical products, previously said the offer was not in the best interests of its shareholders.

Regarding the decision to off-load its entire Sigma shareholding, API said its board decided that the strategic and commercial "fundamentals" that made the merger a compelling proposition have "significantly diminished."

Camberwell, Australia-based API engages in the wholesale distribution of pharmaceutical, medical, health, beauty and lifestyle products to pharmacies primarily in Australia.